Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) Selling, General & Administrative Expenses

The sg&a expense for Stryker Corporation (SYK) is $8.65 Billion with a year-over-year change of +15.27%. Selling, General & Administrative (SG&A) expenses include all costs related to selling products and running the business that are not directly tied to production.

SYK SG&A Expense Chart

SYK SG&A Expense
$8.65B+366.74% 20Y
Zoom

Current SG&A Expense

$8.65B

$8.65 Billion

Year-over-Year Change

+15.27%

vs. $7.50B prior year

Historical Data

30

Years of data available

Annual SG&A Expense History

YearSG&A ExpenseYoY Change% Change
2025$8.65B+$1.15B+15.27%
2024$7.50B+$585.00M+8.45%
2023$6.92B+$844.00M+13.89%
2022$6.08B+$263.00M+4.52%
2021$5.81B+$993.00M+20.60%
2020$4.82B$-203.00M-4.04%
2019$5.02B+$389.00M+8.39%
2018$4.63B+$285.00M+6.55%
2017$4.35B+$395.00M+9.99%
2016$3.95B+$444.00M+12.65%
2015$3.51B+$130.00M+3.85%
2014$3.38B+$72.00M+2.18%
2013$3.31B$-80.00M-2.36%
2012$3.39B+$304.00M+9.86%
2011$3.08B+$352.40M+12.90%
2010$2.73B+$287.80M+11.78%
2009$2.44B$-181.30M-6.91%
2008$2.63B+$233.60M+9.77%
2007$2.39B+$329.80M+16.00%
2006$2.06B+$208.20M+11.23%
2005$1.85B+$201.30M+12.18%
2004$1.65B+$236.20M+16.68%
2003$1.42B+$250.60M+21.50%
2002$1.17B+$180.00M+18.27%
2001$985.40M+$99.80M+11.27%
2000$885.60M+$77.20M+9.55%
1999$808.40M+$427.20M+112.07%
1998$381.20M+$39.70M+11.63%
1997$341.50M+$14.90M+4.56%
1996$326.60M
Data as of Wednesday, June 17, 2026

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo